Cogent Historical Income Statement
| COGT Stock | USD 6.71 0.28 4.01% |
Historical analysis of Cogent Biosciences income statement accounts such as Interest Expense of 4.8 M, Selling General Administrative of 41.5 M or Total Revenue of 0.0 can show how well Cogent Biosciences performed in making a profits. Evaluating Cogent Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cogent Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Cogent Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cogent Biosciences is a good buy for the upcoming year.
Cogent |
About Cogent Income Statement Analysis
Cogent Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cogent Biosciences shareholders. The income statement also shows Cogent investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Cogent Biosciences Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cogent Biosciences. It is also known as Cogent Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Cogent Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cogent Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cogent Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Cogent Stock please use our How to Invest in Cogent Biosciences guide.At this time, Cogent Biosciences' Interest Expense is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 41.5 M in 2025, despite the fact that Operating Income is likely to grow to (178 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Income | 4.0M | 11.3M | 13.0M | 13.7M | Net Interest Income | 4.0M | 11.3M | 13.0M | 13.7M |
Cogent Biosciences income statement Correlations
Click cells to compare fundamentals
Cogent Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cogent Biosciences income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 720K | 147K | 5.9M | 2.3M | 2.6M | 1.7M | |
| Selling General Administrative | 17.4M | 19.6M | 26.2M | 34.4M | 39.5M | 41.5M | |
| Gross Profit | 7.8M | (147K) | (5.9M) | (3.6M) | (3.2M) | (3.1M) | |
| Other Operating Expenses | 90.1M | 75.6M | 147.8M | 208.1M | 239.3M | 251.3M | |
| Operating Income | (82.2M) | (75.6M) | (147.8M) | (208.1M) | (187.3M) | (178.0M) | |
| Ebit | (35.3M) | (75.6M) | (147.8M) | (208.1M) | (187.3M) | (178.0M) | |
| Research Development | 72.6M | 55.9M | 121.6M | 170.2M | 195.7M | 205.5M | |
| Ebitda | (34.6M) | (75.4M) | (142.0M) | (205.9M) | (185.3M) | (176.0M) | |
| Total Operating Expenses | 90.1M | 75.6M | 147.8M | 208.1M | 239.3M | 251.3M | |
| Income Before Tax | (74.8M) | (72.3M) | (140.2M) | (192.4M) | (173.2M) | (164.5M) | |
| Net Income | (66.5M) | (71.8M) | (132.6M) | (192.4M) | (173.2M) | (164.5M) | |
| Net Interest Income | 144K | 467K | 4.0M | 11.3M | 13.0M | 13.7M | |
| Interest Income | 144K | 467K | 4.0M | 11.3M | 13.0M | 13.7M | |
| Net Income From Continuing Ops | (74.8M) | (72.3M) | (140.2M) | (177.7M) | (159.9M) | (151.9M) | |
| Total Other Income Expense Net | 7.4M | 3.3M | 7.6M | 15.7M | 18.1M | 19.0M | |
| Income Tax Expense | (1.6M) | (8.4M) | (467K) | (7.6M) | (6.8M) | (6.5M) | |
| Reconciled Depreciation | 720K | 147K | 5.9M | 3.7M | 4.3M | 2.2M | |
| Cost Of Revenue | 25.7K | 147K | 5.9M | 3.6M | 4.1M | 2.1M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cogent Stock Analysis
When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.